0000899243-21-026782.txt : 20210630 0000899243-21-026782.hdr.sgml : 20210630 20210630180049 ACCESSION NUMBER: 0000899243-21-026782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210628 FILED AS OF DATE: 20210630 DATE AS OF CHANGE: 20210630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOPER GRAHAM K CENTRAL INDEX KEY: 0001396943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39208 FILM NUMBER: 211063098 MAIL ADDRESS: STREET 1: C/O RECEPTOS, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beam Therapeutics Inc. CENTRAL INDEX KEY: 0001745999 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-327-8775 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-28 0 0001745999 Beam Therapeutics Inc. BEAM 0001396943 COOPER GRAHAM K C/O BEAM THERAPEUTICS INC., 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2021-06-28 4 M 0 12045 17.00 A 12045 D Common Stock 2021-06-28 4 S 0 5787 105.37 D 6258 D Common Stock 2021-06-28 4 S 0 3196 106.28 D 3062 D Common Stock 2021-06-28 4 S 0 1162 107.22 D 1900 D Common Stock 2021-06-28 4 S 0 900 108.30 D 1000 D Common Stock 2021-06-28 4 S 0 1000 109.39 D 0 D Stock Option (Right to Buy) 17.00 2021-06-28 4 M 0 12045 0.00 D 2030-02-05 Common Stock 12045 19175 D The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.98, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.77, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.60, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.12 to $108.60, inclusive. The option vests as to one third on the first anniversary of the of the vesting commencement date, February 5, 2020, and at a rate of 4.17% each month thereafter until the option is fully vested. By: /s/ Christine Bellon, Attorney-in-fact 2021-06-30